STRYKER CORP | 41,082 Euro | +0,202 +0,49 % | |
| WKN: 864952 ISIN: US8636671013 Ticker-Symbol: SYK | Frankfurt | 25.05.12 | 18:23 Uhr |
Branche PharmaAktienmarkt S&P 500 |
|
| ||||||||||||||
| Zeit | Aktuelle Nachrichten | Leser | Medien | |
|---|---|---|---|---|
| 26.05. | Stryker is Among the Companies in the Health Care Equipment Industry With the Highest Level of Cash | - | SmarTrend | |
| 25.05. | Stryker gibt positive klinische Ergebnisse für das Trevo® Retriever-System bekannt | 64 | news aktuell | |
| Kalamazoo, Michigan (ots/PRNewswire) -- Ergebnis der Studie zeigt deutlich verbesserte Revaskularisierung im Vergleich mit älteren Geräten; ein Meilenstein in der technologischen Entwicklung der SchlaganfallbehandlungKALAMAZOO... Mehr lesen zu: Stryker gibt positive klinische Ergebnisse für das Trevo® Retriever-System bekannt | ||||
| 24.05. | Stryker Announces Positive Clinical Results From The Trevo® Retriever System | 33 | PR Newswire | |
| - Study results show significantly improved revascularization over previous devices, marking an advancement for technology used in acute stroke care
KALAMAZOO, Michigan, May 24, 2012 /PRNewswire/... Mehr lesen zu: Stryker Announces Positive Clinical Results From The Trevo® Retriever System | ||||
| 22.05. | Will Stryker Help You Retire Rich? | 6 | Motley Fool | |
| 15.05. | Stryker Deploys Camstar to Enable Growth, Efficiency and Top Product Quality | 8 | Business Wire | |
| Manufacturing Execution System (MES) Ensures Process Enforcement and
Timely, Accurate Information across the Business
Camstar Systems, Inc. announced... Mehr lesen zu: Stryker Deploys Camstar to Enable Growth, Efficiency and Top Product Quality | ||||
| 02.05. | Research on CareFusion Corporation and Stryker Corporation -- Medical Instrument Makers Consistent | 34 | MarketWire | |
| JOHANNESBURG, SOUTH AFRICA -- (Marketwire) -- 05/02/12 -- www.stockcall.com/ offers investors comprehensive research on the Medical Instruments & Supplies industry and has completed analytical research... Mehr lesen zu: Research on CareFusion Corporation and Stryker Corporation -- Medical Instrument Makers Consistent | ||||
| 30.04. | Stryker Co-Founds Coalition to Advance Purchase of Environmentally-Preferable Healthcare Products | 33 | Business Wire | |
| CleanMed, Booth #313 – Stryker,
a leader in medical device reprocessing, has co-founded a coalition of
17 elite healthcare suppliers with Practice Greenhealth to advance... Mehr lesen zu: Stryker Co-Founds Coalition to Advance Purchase of Environmentally-Preferable Healthcare Products | ||||
| 24.04. | STRYKER CORP - 10-K/A, Annual Report | 2 | SEC Filings | |
| 24.04. | Dr. Charles Stryker And Tom Reddin Appointed To Datamyx Board Of Directors | 14 | PR Newswire | |
| BOCA RATON, Fla., April 24, 2012 /PRNewswire/ -- Datamyx, a premier automated marketing information services company, today announced that Dr. Charles W. Stryker and Tom Reddin have... Mehr lesen zu: Dr. Charles Stryker And Tom Reddin Appointed To Datamyx Board Of Directors | ||||
| 22.04. | Highest Level of Cash in the Health Care Equipment Industry Detected in Shares of Stryker | 3 | SmarTrend | |
| 21.04. | Stryker has the Highest Level of Cash in the Health Care Equipment Industry | 1 | SmarTrend | |
| 18.04. | Medizintechniker Stryker erfüllt Gewinnerwartungen | 77 | BörseGo | |
| New York (BoerseGo.de) - Der Medizintechniker Stryker hat im ersten Quartal beim Gewinn die Erwartungen der Wall Street erfüllt. Der Umsatz traf fast exakt den Konsens. Stryker ist ein Hersteller von... Mehr lesen zu: Medizintechniker Stryker erfüllt Gewinnerwartungen | ||||
| 18.04. | Stryker Profit Rises 14%, In Line | 87 | AFX News | |
| WASHINGTON (dpa-AFX) - Medical device maker Stryker Corp. (SYK), Tuesday
reported a 14 percent increase in profit for the first quarter, driven mainly by
higher gross margins and revenues.... Mehr lesen zu: Stryker Profit Rises 14%, In Line | ||||
| 17.04. | Stryker Q1 Profit Rises | 55 | AFX News | |
| WASHINGTON (dpa-AFX) - Stryker Corp. (SYK) reported that its first-quarter
net earnings were $350 million or $0.91 per share, compared with $307 million or
$0.78 per share in the same quarter... Mehr lesen zu: Stryker Q1 Profit Rises | ||||
| 17.04. | UPDATE 1-Stryker profit in line with analyst forecasts | 2 | Reuters.com | |
| 17.04. | New Stryker Device Offers Hospitals Environmental and Bottom-line Benefits | 27 | Business Wire | |
| Stryker's
Sustainability Solutions division, a leader in medical
device reprocessing, today introduced Restep®, the company's
pioneering deep vein thrombosis (DVT)... Mehr lesen zu: New Stryker Device Offers Hospitals Environmental and Bottom-line Benefits | ||||
| 13.04. | Stryker Bearish Moving Average Crossover Alert | 1 | SmarTrend | |
| 12.04. | NeuroLogica Corporation Announces Partnership with Stryker | 83 | Business Wire | |
| Partnership to enhance surgical outcomes and ensure accuracy
NeuroLogica Corporation and Stryker Navigation, a business unit of
Stryker Corporation,... Mehr lesen zu: NeuroLogica Corporation Announces Partnership with Stryker | ||||
| 28.03. | XFRA DIVIDEND INFORMATION - 28.03.2012 - 2 | 70 | Xetra Newsboard | |
| FOLGENDE WERTPAPIERE WERDEN AM 28.03.2012 EX DIVIDENDE GEHANDELT.
THE EX-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 28.03.2012.
INSTR EXCH ISIN INSTRUMENT NAME DIVIDEND AMOUNT
PRL XFRA US7512121010... Mehr lesen zu: XFRA DIVIDEND INFORMATION - 28.03.2012 - 2 | ||||
| 27.03. | XFRA DIVIDEND INFORMATION - 28.03.2012 - 1 | 25 | Xetra Newsboard | |
| FOLGENDE WERTPAPIERE WERDEN AM 27.03.2012 CUM DIVIDENDE UND AM 28.03.2012
EX DIVIDENDE GEHANDELT.
THE PRE-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 27.03.2012. THE
EX-DIVIDEND DAY WILL BE 28.03.2012.
... Mehr lesen zu: XFRA DIVIDEND INFORMATION - 28.03.2012 - 1 | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| PFIZER INC | 17,800 | +1,22 % | Pfizer renal cell carcinoma therapy receives positive opinion from CHMP |
| NOVARTIS AG | 41,600 | +0,63 % | Novartis-Präsident Vasella kritisiert die Einwanderungspolitik |
| CELESIO AG | 11,750 | +0,30 % | Celesio AG: Neues 13-Wochentief (11.71 Euro, Short) |
| NOVO NORDISK A/S | 113,60 | +2,43 % | FDA approves extended use of Novo Nordisk Levemir insulin in children |
| GILEAD SCIENCES INC | 40,071 | -0,24 % | Erfolg für GILEAD |
Startseite • Nachrichten • Aktienkurse • Xetra-Orderbuch • Watchlist
Ad hoc-Mitteilungen • Chartanalysen • Nachrichten Börsen • Aktien-Empfehlungen
Branchen • Medien • Nachrichten-Archiv
Impressum | AGB | Disclaimer • Presse • Mediadaten
RSS-News von FinanzNachrichten.de kostenlos für Ihren Browser und Ihre Homepage
